Current role of liver transplantation for methylmalonic acidemia: A review of the literature

Mureo Kasahara; Reiko Horikawa; Manabu Tagawa; Shinji Uemoto; Satoshi Yokoyama; Yumiko Shibata; Takafumi Kawano; Tatsuo Kuroda; Toshiro Honna; Koichi Tanaka; Morihiro Saeki

doi:10.1111/j.1399-3046.2006.00585.x

Current role of liver transplantation for methylmalonic acidemia: A review of the literature

Mureo Kasahara, Reiko Horikawa, Manabu Tagawa, Shinji Uemoto, Satoshi Yokoyama, Yumiko Shibata, Takafumi Kawano, Tatsuo Kuroda, Toshiro Honna, Koichi Tanaka, Morihiro Saeki

Research output: Contribution to journal › Article

70 Citations (Scopus)

Abstract

To evaluate the current role of liver transplantation (LT) for methylmalonic acidemia (MMA), we reviewed the literature on outcomes of this treatment, and describe three of our own cases of living-donor liver transplantation (LDLT). The total number of LT cases identified was 18. Transplantation mode was deceased donor LT in 12, including five combined liver-kidney transplantations (CLKT) from deceased donors, and LDLT in six. Three hospital mortalities were noted, because of metabolic decompensation, sepsis and aspergillosis. Although mean postoperative serum MMA level decreased to 13.8% ± 9.2% (range 1.25-26.1%) of preoperative levels, four patients (22.2%) had renal insufficiency after isolated LT and three (16.7%) had postoperative neurological disability. Continuing metabolic damage to the kidney and brain may occur even after successful LT. Further evaluation is required to determine the long-term suitability of this treatment modality.

Original language	English
Pages (from-to)	943-947
Number of pages	5
Journal	Pediatric Transplantation
Volume	10
Issue number	8
DOIs	https://doi.org/10.1111/j.1399-3046.2006.00585.x
Publication status	Published - 2006 Dec 1
Externally published	Yes

Keywords

Liver transplantation
Living donor
Metabolic
Organic acidemia

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Transplantation

Access to Document

10.1111/j.1399-3046.2006.00585.x

Fingerprint Dive into the research topics of 'Current role of liver transplantation for methylmalonic acidemia: A review of the literature'. Together they form a unique fingerprint.

Cite this

Kasahara, M., Horikawa, R., Tagawa, M., Uemoto, S., Yokoyama, S., Shibata, Y., Kawano, T., Kuroda, T., Honna, T., Tanaka, K., & Saeki, M. (2006). Current role of liver transplantation for methylmalonic acidemia: A review of the literature. Pediatric Transplantation, 10(8), 943-947. https://doi.org/10.1111/j.1399-3046.2006.00585.x

Current role of liver transplantation for methylmalonic acidemia : A review of the literature. / Kasahara, Mureo; Horikawa, Reiko; Tagawa, Manabu; Uemoto, Shinji; Yokoyama, Satoshi; Shibata, Yumiko; Kawano, Takafumi; Kuroda, Tatsuo; Honna, Toshiro; Tanaka, Koichi; Saeki, Morihiro.

In: Pediatric Transplantation, Vol. 10, No. 8, 01.12.2006, p. 943-947.

Research output: Contribution to journal › Article

@article{c7af4193699e4723b66c583fd086d6da,

title = "Current role of liver transplantation for methylmalonic acidemia: A review of the literature",

abstract = "To evaluate the current role of liver transplantation (LT) for methylmalonic acidemia (MMA), we reviewed the literature on outcomes of this treatment, and describe three of our own cases of living-donor liver transplantation (LDLT). The total number of LT cases identified was 18. Transplantation mode was deceased donor LT in 12, including five combined liver-kidney transplantations (CLKT) from deceased donors, and LDLT in six. Three hospital mortalities were noted, because of metabolic decompensation, sepsis and aspergillosis. Although mean postoperative serum MMA level decreased to 13.8% ± 9.2% (range 1.25-26.1%) of preoperative levels, four patients (22.2%) had renal insufficiency after isolated LT and three (16.7%) had postoperative neurological disability. Continuing metabolic damage to the kidney and brain may occur even after successful LT. Further evaluation is required to determine the long-term suitability of this treatment modality.",

keywords = "Liver transplantation, Living donor, Metabolic, Organic acidemia",

author = "Mureo Kasahara and Reiko Horikawa and Manabu Tagawa and Shinji Uemoto and Satoshi Yokoyama and Yumiko Shibata and Takafumi Kawano and Tatsuo Kuroda and Toshiro Honna and Koichi Tanaka and Morihiro Saeki",

year = "2006",

month = dec,

day = "1",

doi = "10.1111/j.1399-3046.2006.00585.x",

language = "English",

volume = "10",

pages = "943--947",

journal = "Pediatric Transplantation",

issn = "1397-3142",

publisher = "Wiley-Blackwell",

number = "8",

}

TY - JOUR

T1 - Current role of liver transplantation for methylmalonic acidemia

T2 - A review of the literature

AU - Kasahara, Mureo

AU - Horikawa, Reiko

AU - Tagawa, Manabu

AU - Uemoto, Shinji

AU - Yokoyama, Satoshi

AU - Shibata, Yumiko

AU - Kawano, Takafumi

AU - Kuroda, Tatsuo

AU - Honna, Toshiro

AU - Tanaka, Koichi

AU - Saeki, Morihiro

PY - 2006/12/1

Y1 - 2006/12/1

N2 - To evaluate the current role of liver transplantation (LT) for methylmalonic acidemia (MMA), we reviewed the literature on outcomes of this treatment, and describe three of our own cases of living-donor liver transplantation (LDLT). The total number of LT cases identified was 18. Transplantation mode was deceased donor LT in 12, including five combined liver-kidney transplantations (CLKT) from deceased donors, and LDLT in six. Three hospital mortalities were noted, because of metabolic decompensation, sepsis and aspergillosis. Although mean postoperative serum MMA level decreased to 13.8% ± 9.2% (range 1.25-26.1%) of preoperative levels, four patients (22.2%) had renal insufficiency after isolated LT and three (16.7%) had postoperative neurological disability. Continuing metabolic damage to the kidney and brain may occur even after successful LT. Further evaluation is required to determine the long-term suitability of this treatment modality.

AB - To evaluate the current role of liver transplantation (LT) for methylmalonic acidemia (MMA), we reviewed the literature on outcomes of this treatment, and describe three of our own cases of living-donor liver transplantation (LDLT). The total number of LT cases identified was 18. Transplantation mode was deceased donor LT in 12, including five combined liver-kidney transplantations (CLKT) from deceased donors, and LDLT in six. Three hospital mortalities were noted, because of metabolic decompensation, sepsis and aspergillosis. Although mean postoperative serum MMA level decreased to 13.8% ± 9.2% (range 1.25-26.1%) of preoperative levels, four patients (22.2%) had renal insufficiency after isolated LT and three (16.7%) had postoperative neurological disability. Continuing metabolic damage to the kidney and brain may occur even after successful LT. Further evaluation is required to determine the long-term suitability of this treatment modality.

KW - Liver transplantation

KW - Living donor

KW - Metabolic

KW - Organic acidemia

UR - http://www.scopus.com/inward/record.url?scp=33750600921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750600921&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2006.00585.x

DO - 10.1111/j.1399-3046.2006.00585.x

M3 - Article

C2 - 17096763

AN - SCOPUS:33750600921

VL - 10

SP - 943

EP - 947

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 8

ER -